China
Chung Shan Medical University - Institute of Medicine
Systemic lupus erythematosus, All-Cause Mortality, Healthcare Utilization, Anifrolumab, Type I interferon, Belimumab, anti-Blys, anti-BAFF, Biological therapy, Biologics
EGFR-TKI, osimertinib, cardiotoxicity, non-small cell lung cancer, real-world data
Psoriasis, Arthropathic Psoriasis, IL23 Inhibitors, IL12/23 Inhibitors, Biologic Agents, Safety Profile, Retrospective Cohort Study
immune associated thrombocytopenia, COVID-19, ITP, APS, TMA, MDS, CTDs
Inflammatory bowel diseases, tonsillectomy
Maternal Autoimmune Diseases, Maternal Immune Activation, Tics and Tourette's Disorder, Maternal and Child Health Database, Taiwan NHIRD
Type 1 diabetes mellitus, Pay-for-performance, Hospitalization
COVID-19, immune-related thrombocytopenia, CTD, ITP, APS, TMA, MDS
Tonsillectomy, Chronic rhinosinusitis, Upper airway inflammation, Cohort study, Propensity score matching, Surgical outcomes, Risk stratification, Respiratory health, ENT surgery, TriNetX database.
all-cause dementia, Alzheimer's disease, vascular dementia, unspecified dementia, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, type 2 diabetes
Tonsillectomy, Oropharyngeal Carcinoma
endoscopic retrograde cholangiopancreatography, cholecystectomy, pancreaticobiliary cancer, ampullary cancer
PCSK9 inhibitor, Erectile dysfunction, Statin, Hyperlipidemia, TriNetX
Multiple sclerosis, neurological autoimmune diseases, type 2 diabetes, sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, emulated target trial